欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1250/001
药品名称Azelastine/Fluticasone Newbury 125 mikrog + 50 mikrog
活性成分
    • Azelastine hydrochloride 137.0 µg
    • Fluticasone propionate 50.0 µg
剂型Nasal spray, suspension
上市许可持有人Newbury Pharmaceuticals AB, Medicon Village, Scheele Torget 1, 223 81 Lund, Sverige
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Denmark (DK)
      Azelastine hydrochloride/Fluticasone ”Newbury”
    • Sweden (SE)
    • Norway (NO)
许可日期2024/11/20
最近更新日期2025/02/14
药物ATC编码
    • R01AD58 fluticasone, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase